A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
Clinical trial NCT00567710 · COMPLETED
Trial details
- NCT number
- NCT00567710
- Sponsor
- BioLineRx, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-07-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.